Ishii Euma, Ebner Daniel K, Kimura Satoshi, Agha-Mir-Salim Louis, Uchimido Ryo, Celi Leo A
1Department of Global Health Promotion, Tokyo Medical and Dental University, 1 Chome-5-45 Yushima, Bunkyo City, Tokyo, 113-8510 Japan.
2Department of Intensive Care Medicine, Tokyo Medical and Dental University, 1 Chome-5-45 Yushima, Bunkyo City, Tokyo, 113-8510 Japan.
J Intensive Care. 2020 May 18;8:35. doi: 10.1186/s40560-020-00452-5. eCollection 2020.
Artificial intelligence or AI has been heralded as the most transformative technology in healthcare, including critical care medicine. Globally, healthcare specialists and health ministries are being pressured to create and implement a roadmap to incorporate applications of AI into care delivery. To date, the majority of Japan's approach to AI has been anchored in industry, and the challenges that have occurred therein offer important lessons for nations developing new AI strategies. Notably, the demand for an AI-literate workforce has outpaced training programs and knowledge. This is particularly observable within medicine, where clinicians may be unfamiliar with the technology. National policy and private sector involvement have shown promise in developing both workforce and AI applications in healthcare. In combination with Japan's unique national healthcare system and aggregable healthcare and socioeconomic data, Japan has a rich opportunity to lead in the field of medical AI.
人工智能（AI）被誉为医疗保健领域，包括重症监护医学领域最具变革性的技术。在全球范围内，医疗保健专家和卫生部面临着制定并实施将人工智能应用纳入医疗服务路线图的压力。迄今为止，日本对人工智能的应用主要集中在工业领域，其中出现的挑战为正在制定新人工智能战略的国家提供了重要教训。值得注意的是，对具备人工智能知识的劳动力的需求超过了培训计划和知识储备。这在医学领域尤为明显，临床医生可能对该技术并不熟悉。国家政策和私营部门的参与在发展医疗保健领域的劳动力和人工智能应用方面已显示出成效。结合日本独特的国家医疗保健系统以及可汇总的医疗保健和社会经济数据，日本在医疗人工智能领域拥有引领潮流的丰富机遇。
